Critical role for D-type cyclins in cellular transformation induced by E6/E7 of human papillomavirus type 16 and E6/E7/ErbB-2 cooperation

Cancer Science

Volumn 98, Issue 7, 2007, Pages 973-977

  Yasmeen, Amber ^a,b   Hosein, Abdel N ^a,b   Yu, Qunyan ^c,d   Al Moustafa, Ala Eddin ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; CYCLIN D; CYCLIN D1; CYCLIN D2; CYCLIN D3; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTEIN E6; PROTEIN E7; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CANCER THERAPY; CARCINOGENESIS; CELL TRANSFORMATION; COLONY FORMATION; CONTROLLED STUDY; EMBRYO CELL; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IN VITRO STUDY; IN VIVO STUDY; INFECTION RISK; MALIGNANT TRANSFORMATION; MOUSE; MOUTH MUCOSA; MUCOSA CELL; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL;

ANIMALS; CELL LINE; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; COLONY-FORMING UNITS ASSAY; CYCLINS; FIBROBLASTS; HUMAN PAPILLOMAVIRUS 16; HUMANS; MICE; MICE, NUDE; MOUTH MUCOSA; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; PAPILLOMAVIRUS INFECTIONS; RECEPTOR, ERBB-2; RNA, SMALL INTERFERING;

EID: 34249883352     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2007.00504.x     Document Type: Article

References (26)

1. Gasco M, Crook T. The p53 network in head and neck cancer. Oral Oncol 2003; 39: 222-31.
2. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: A meta-analysis. Br J Cancer 2003; 88: 63-73.
3. Gillison ML, Koch WM, Capone RB et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000; 92: 709-20.
4. Venuti A, Badaracco G, Rizzo C, Mafera B, Rahimi S, Vigili M. Presence of HPV in head and neck tumours: High prevalence in tonsillar localization. J Exp Clin Cancer Res 2004; 23: 561-6.
5. Moreno V, Bosch FX, Munoz N et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: The IARC multicentric case-control study. Lancet 2002; 359: 1085-92.
6. Khan MJ, Castle PE, Lorincz AT et al. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 2005; 97: 1072-9.
7. Bei R, Budillon A, Masuelli L et al. Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients. J Pathol 2004; 204: 317-25.
8. Chen CH, Lin YS, Lin CC, Yang YH, Ho YP, Tsai CC. Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients. J Oral Pathol Med 2004; 33: 589-94.
9. Niibe Y, Nakano T, Ohno T, Suzuki Y, Oka K, Tsujii H. Prognostic significance of c-erbB-2/HER2 expression in advanced uterine cervical carcinoma with para-aortic lymph node metastasis treated with radiation therapy. Int J Gynecol Cancer 2003; 13: 849-55.
10. Lee JS, Kim HS, Jung JJ, Lee MC, Park CS. Expression of vascular endothelial growth factor in adenocarcinomas of the uterine cervix and its relation to angiogenesis and p53 and c-erbB-2 protein expression. Gynecol Oncol 2002; 85: 469-75.
11. Cheung TH, Yu MM, Lo KW, Yim SF, Chung TK, Wong YF. Alteration of cyclin D1 and CDK4 gene in carcinoma of uterine cervix. Cancer Lett 2001; 166: 199-206.
12. Rousseau A, Lim MS, Lin Z, Jordan RC. Frequent cyclin D1 gene amplification and protein overexpression in oral epithelial dysplasias. Oral Oncol 2001; 37: 268-75.
13. Almadori G, Galli J, Cadoni G, Bussu F, Maurizi M. Human papillomavirus infection and cyclin D1 gene amplification in laryngeal squamous cell carcinoma: Biologic function and clinical significance. Head Neck 2002; 24: 597-604.
14. Al Moustafa AE, Foulkes WD, Benlimame N et al. E6/E7 proteins of HPV type 16 and ErbB-2 cooperate to induce neoplastic transformation of primary normal oral epithelial cells. Oncogene 2004; 23: 350-8.
15. Shtutman M, Zhurinsky J, Simcha I et al. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 1999; 96: 5522-7.
16. Lin SY, Xia W, Wang JC et al. Beta-catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA 2000; 97: 4262-6.
17. Yu Q, Geng Y, Sicinski P. Specific protection against breast cancers by cyclin D1 ablation. Nature 2001; 411: 1017-21.
18. Al Moustafa AE, Foulkes WD, Wong A et al. Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cells. Oncogene 2004; 23: 5252-6.
19. Liu SC, Bassi DE, Zhang SY, Holoran D, Conti CJ, Klein-Szanto AJ. Overexpression of cyclin D2 is associated with increased in.vivo invasiveness of human squamous carcinoma cells. Mol Carcinog 2002; 34: 131-9.
20. Decker T, Schneller F, Hipp S et al. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27. Leukemia 2002; 16: 327-34.
21. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002; 296: 550-3.
22. Robles AI, Rodriguez-Puebla ML, Glick AB et al. Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in.vivo. Genes Dev 1998; 12: 2469-74.
23. Jena N, Deng M, Sicinska E, Sicinski P, Daley GQ. Critical role for cyclin D2 in BCR/ABL-induced proliferation of hematopoietic cells. Cancer Res 2002; 62: 535-4.
24. Sicinska E, Aifantis I, Le Cam L et al. Requirement for cyclin D3 in lymphocyte development and T cell leukemias. Cancer Cell 2003; 4: 451-61.
25. Kozar K, Ciemerych MA, Rebel VI et al. Mouse development and cell proliferation in the absence of D-cyclins. Cell 2004; 118: 477-91.
26. Yu Q, Sicinska E, Geng Y et al. Requirement for CDK4 kinase function in breast cancer. Cancer Cell 2006; 9: 23-32.